Search This Blog

Friday, September 25, 2026

Novo signs deal worth up to EUR 1.165bn with Sweden's Nanexa

 

The Danish drugmaker gains access to Nanexa’s drug delivery technology, which could allow monthly or quarterly dosing of weight-loss and diabetes treatments.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)